A detailed history of Ascent Wealth Partners, LLC transactions in Shockwave Medical, Inc. stock. As of the latest transaction made, Ascent Wealth Partners, LLC holds 12,245 shares of SWAV stock, worth $0. This represents 0.59% of its overall portfolio holdings.

Number of Shares
12,245
Previous 11,993 2.1%
Holding current value
$0
Previous $2.29 Million 74.49%
% of portfolio
0.59%
Previous 0.37%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$191.17 - $325.63 $48,174 - $82,058
252 Added 2.1%
12,245 $3.99 Million
Q4 2023

Jan 22, 2024

BUY
$160.99 - $215.69 $327,131 - $438,282
2,032 Added 20.4%
11,993 $2.29 Million
Q3 2023

Oct 20, 2023

BUY
$194.33 - $283.97 $856,217 - $1.25 Million
4,406 Added 79.32%
9,961 $1.98 Million
Q2 2023

Aug 04, 2023

BUY
$223.05 - $302.68 $60,446 - $82,026
271 Added 5.13%
5,555 $1.59 Million
Q1 2023

Apr 25, 2023

BUY
$175.41 - $217.92 $14,909 - $18,523
85 Added 1.63%
5,284 $1.15 Million
Q4 2022

Feb 02, 2023

BUY
$204.38 - $296.82 $5,313 - $7,717
26 Added 0.5%
5,199 $1.07 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $83,354 - $132,596
-427 Reduced 7.63%
5,173 $1.44 Million
Q2 2022

Aug 10, 2022

SELL
$115.91 - $214.48 $592,531 - $1.1 Million
-5,112 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$127.96 - $207.36 $3,071 - $4,976
24 Added 0.47%
5,112 $1.06 Million
Q4 2021

Jan 27, 2022

BUY
$165.13 - $241.83 $37,814 - $55,379
229 Added 4.71%
5,088 $908,000
Q3 2021

Nov 01, 2021

SELL
$163.99 - $235.57 $5,247 - $7,538
-32 Reduced 0.65%
4,859 $1 Million
Q2 2021

Jul 30, 2021

BUY
$131.45 - $201.49 $642,921 - $985,487
4,891 New
4,891 $928,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Ascent Wealth Partners, LLC Portfolio

Follow Ascent Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Wealth Partners, LLC with notifications on news.